Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Evonik Expands Production Facilities | Contract Pharma

What are you searching for?

Sign in
Breaking News

Evonik Expands Production Facilities

Adds capacity to produce biodegradable polymers

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Evonik is expanding its production facilities in Birmingham, AL and Darmstadt, Germany for additional capacity to produce biodegradable polymers marketed globally as RESOMER and RESOMER SELECT. These poly-lactic-glycolic-acid (PLGA) copolymers are primarily used to manufacture bioresorbable medical devices and controlled-release formulations for parenteral drug delivery.    
 
“We expect the global demand for biodegradable polymers to continue to grow in the coming years,” said Paul Spencer, head of Biomaterials at Evonik’s Health Care Business Line. “With this in mind, we are currently investing to increase the capacity of our production facilities in order to serve our global customer base.”   
 
The company will add new building adjacent to its existing facility in Birmingham, with greater production capacity, as well as clean rooms and a lab for polymer contract research projects. Commissioning is slated for late 2018.    
 
The company will also be opening a new production line in Darmstadt, along with an applied technology lab to support medical device customers.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics